Efficacy of methylprednisolone in very early systemic sclerosis: results of the "Hit hard and early'' randomized controlled trial.
Brigit E KerstenJacqueline M J LemmersAmber VanhaeckeArthiha VelauthapillaiWieneke M T van den HomberghFrank H J van den HoogenCornelia H M van den EndeVanessa SmithMadelon C VonkPublished in: Rheumatology (Oxford, England) (2024)
No clinically relevant effect of short-term methylprednisolone in patients with very early Systemic Sclerosis was observed. A substantial proportion of patients showed disease progression.